The high cost of IVF services limits the market for in vitro fertilizations (IVF). For example, the cost of a basic IVF package ranges from $4,700 to $20,000, with the average price in the US being $12,000. The total cost of a single IVF cycle is also between $8,000 and $30,000.
The cost of IVF in the Asia-Pacific region is lower than that of India and comparable to that of industrialized regions. The growth of medical tourism in the region and IVF are expected to complement the growth of the Asia-Pacific IVF market in the region.
In vitro fertilization is open to heterosexual couples, lesbian couples and single women. The Quebec government plans to introduce IVF as a state-funded health service. It is estimated that this represents a groundbreaking development in the market for infertility treatment devices. IVF costs at least $6,000, not counting the cost of the hormones the patient takes.
The various treatment options available today are simple, affordable, effective, and promising. This involves increasing the number of eggs and sperm and bringing them together to improve the chances of pregnancy. These treatments are known as assisted reproductive technologies (ART) and include in vitro fertilizations (IVF).
Fertilizations is an artificial insemination in which an egg is taken from a woman's ovaries and fertilized with sperm. The idea is to stimulate the woman to ovulate (to remove the egg from her ovaries) and then have the sperm fertilize the egg in a fluid in a laboratory.
The Asia-Pacific IVF services market is segmented by cycle type, end user and country. The growing trend of delayed pregnancies among women is expected to drive the growth of the IVF services market. The cycle on the market is divided into fresh IVF cycles (non-donor), defrosting IVF cycles (non-donor) and IVF cycles of the donor.
Based on the type of cycle, the fresh IVF cycle non-donor segment will account for the lion's share in 2020, accounting for two-thirds of the Asia-Pacific IVF services market. The defrosted IVF cycle segment outside the donor segment is estimated to have the highest CAGR of 10.3% over the forecast period.
The fertility clinics segment holds a lion's share of the market in terms of end-users and will account for around three-fifths of the total market by 2020. The market for IVF services in the Asia-Pacific region is segmented by cycle types, end users and regions.
The fertility services market is expected to grow over the forecast period 2021-2028. Data from Bridge Market Research show that the global IVF services market will grow by 9.20% over this period. The increasing and continuous decline in fertility rates is driving the market.
The market for fertility services is segmented on the basis of infertility procedures, services and end users. Based on infertility, the market for fertility services has been divided into male infertility and female infertility. The growth segments help you analyze the lean growth segments of the industry and provide users with a valuable market overview and market insights that help them make strategic decisions and identify the core applications of the market.
The global IVF services market is divided by cycle type, process offering and end user. In terms of cycle types, the market is divided into fresh IVF cycles, donor egg IVF cycles and thawing IvF cycles.
This report presents an in-depth analysis of the market, including demand drivers and competitive dynamics. In addition, the following data is collected from industry leaders and market participants. The report was compiled through extensive primary and secondary research. This analysis helps to provide accurate forecasts for the market over the forecast period.
The report on the global IVF services market highlights that the market is expected to reach $12.5 billion in 2018 and grow to $25.6 billion by 2026, representing a CAGR of 9.3% between 2019 and 2026. The report provides up-to-date market sizes and forecasts along with Porter Five Force analyses to help market participants, stakeholders, startups and investors determine the current scenario and take further steps into the future.
The study provides an in-depth market analysis of IVF services, current trends and future estimates to illustrate the upcoming investment opportunities. It provides a quantitative analysis from 2018 to 2026 to enable stakeholders to benefit from the dominant market size for IVF services. The IVF services market by region (2026) Asia-Pacific: North America, Europe and LAMEA (Asia-Pacific) have the highest CAGR of 12.0% from 2019 to 2026.
The MarketWatch news division was not involved in the creation of this content. February 26, 2021 (Herald keeper) - US IVF Services Market, Cycle Type: Fresh IVF Cycle, Thawed IVF Cycles, Donor Egg IVF Cycle, End User: Fertility Clinics, Hospitals, Surgical Centers, Clinical Research Institutes, Region: Analysis of Market Size, Market Share, Trends, 2019-2020 and Forecast to 2030.
The global IVF services market was estimated at $13.63 billion in 2019 and will grow to $35.53 billion by 2030, representing a CAGR of 9.1% from 2020 to 2030. IVF fertilizations is a type of assisted reproductive technology (ART), in which a female oocyte is taken from an ovary and fertilised under artificial laboratory conditions (GLASS) with high-quality male sperm in order to develop a zygote.
The zygotes are subjected to an embryo culture by a doctor and then implanted in their female uterus to facilitate a successful pregnancy. It is the most common type of artificial insemination used to treat male and female infertility and to support surrogacy. Single parents and LGBT communities are using this technology to reproduce.
Due to the increasing number of IVF treatments, insurance companies offer insurance cover for IVF procedures. This has led to competitive prices and dampened the cost of IVF treatment as the procedure becomes more widespread and technology drives the market with increasing automation and standardization of treatment.
On the other hand, it is estimated that rapid technological advances in IVF treatments will provide lucrative opportunities in the coming period. Based on the type of cycle, the fresh cycles and the non-donor segment contributed more than half of the total market share in 2017. This segment is expected to have the fastest CAGR of 11.1% over the forecast period.